Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
The Market Dynamics of Track One Patent Strateg...
By
Rene Pretorius
September 26, 2025
In the interconnected landscape of pharmaceutical regulation and innovation, the Track One patent strategy in pharmaceuticals serves as an important component that
Biosimilars Market Trends 2025: Understanding Erosion and Growth
Mounjaro Price Increase UK: Impacts on Access and Health Economics
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms
Rare Medications Coverage in the Netherlands: Price Reductions Required
Strengthening the U.S. Pharmaceutical Supply Chain: Establishing a Strategic ...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
Global Health Technology Assessment: Navigating NICE’s Role and Challen...
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
National Bulk Purchasing Strategy: Enhancing Drug Affordability and Access in...
Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...
« Previous
1
2
3
4
5
…
10
Next »